nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—Methylprednisolone—psoriatic arthritis	0.1	0.117	CbGbCtD
Loratadine—CYP2C19—Prednisone—psoriatic arthritis	0.0751	0.0881	CbGbCtD
Loratadine—ABCB1—Betamethasone—psoriatic arthritis	0.065	0.0763	CbGbCtD
Loratadine—ABCB1—Prednisolone—psoriatic arthritis	0.0642	0.0753	CbGbCtD
Loratadine—ABCB1—Prednisone—psoriatic arthritis	0.0606	0.0711	CbGbCtD
Loratadine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0599	0.0703	CbGbCtD
Loratadine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0559	0.0656	CbGbCtD
Loratadine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0469	0.055	CbGbCtD
Loratadine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0454	0.0533	CbGbCtD
Loratadine—CYP2C9—Dexamethasone—psoriatic arthritis	0.039	0.0457	CbGbCtD
Loratadine—CYP3A4—Betamethasone—psoriatic arthritis	0.039	0.0457	CbGbCtD
Loratadine—CYP3A4—Prednisolone—psoriatic arthritis	0.0384	0.0451	CbGbCtD
Loratadine—ABCB1—Dexamethasone—psoriatic arthritis	0.0378	0.0444	CbGbCtD
Loratadine—CYP3A4—Prednisone—psoriatic arthritis	0.0363	0.0426	CbGbCtD
Loratadine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0356	0.0418	CbGbCtD
Loratadine—ABCB1—Methotrexate—psoriatic arthritis	0.0304	0.0357	CbGbCtD
Loratadine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0227	0.0266	CbGbCtD
Loratadine—Increased appetite—Prednisolone—psoriatic arthritis	0.00127	0.00858	CcSEcCtD
Loratadine—Diarrhoea—Auranofin—psoriatic arthritis	0.00126	0.0085	CcSEcCtD
Loratadine—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.00125	0.00844	CcSEcCtD
Loratadine—Vomiting—Auranofin—psoriatic arthritis	0.00117	0.0079	CcSEcCtD
Loratadine—Increased appetite—Triamcinolone—psoriatic arthritis	0.00117	0.00789	CcSEcCtD
Loratadine—Increased appetite—Methylprednisolone—psoriatic arthritis	0.00116	0.00788	CcSEcCtD
Loratadine—Rash—Auranofin—psoriatic arthritis	0.00116	0.00784	CcSEcCtD
Loratadine—Dermatitis—Auranofin—psoriatic arthritis	0.00116	0.00783	CcSEcCtD
Loratadine—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.00115	0.00776	CcSEcCtD
Loratadine—Nausea—Auranofin—psoriatic arthritis	0.00109	0.00738	CcSEcCtD
Loratadine—Increased appetite—Dexamethasone—psoriatic arthritis	0.00106	0.00716	CcSEcCtD
Loratadine—Increased appetite—Betamethasone—psoriatic arthritis	0.00106	0.00716	CcSEcCtD
Loratadine—Hyperkinesia—Prednisone—psoriatic arthritis	0.00104	0.00704	CcSEcCtD
Loratadine—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.00104	0.00704	CcSEcCtD
Loratadine—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.00104	0.00704	CcSEcCtD
Loratadine—Lethargy—Dexamethasone—psoriatic arthritis	0.00101	0.00687	CcSEcCtD
Loratadine—Lethargy—Betamethasone—psoriatic arthritis	0.00101	0.00687	CcSEcCtD
Loratadine—Increased appetite—Prednisone—psoriatic arthritis	0.000922	0.00624	CcSEcCtD
Loratadine—Lethargy—Prednisone—psoriatic arthritis	0.000884	0.00598	CcSEcCtD
Loratadine—Epistaxis—Triamcinolone—psoriatic arthritis	0.000796	0.00539	CcSEcCtD
Loratadine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000752	0.00509	CcSEcCtD
Loratadine—Lethargy—Methotrexate—psoriatic arthritis	0.000738	0.005	CcSEcCtD
Loratadine—Arrhythmia—Prednisolone—psoriatic arthritis	0.000736	0.00498	CcSEcCtD
Loratadine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000683	0.00462	CcSEcCtD
Loratadine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.000677	0.00458	CcSEcCtD
Loratadine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000676	0.00457	CcSEcCtD
Loratadine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000666	0.00451	CcSEcCtD
Loratadine—Depression—Prednisone—psoriatic arthritis	0.000665	0.0045	CcSEcCtD
Loratadine—Angioedema—Prednisolone—psoriatic arthritis	0.000656	0.00444	CcSEcCtD
Loratadine—Malaise—Prednisolone—psoriatic arthritis	0.000647	0.00438	CcSEcCtD
Loratadine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000646	0.00437	CcSEcCtD
Loratadine—Syncope—Prednisolone—psoriatic arthritis	0.000643	0.00435	CcSEcCtD
Loratadine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000631	0.00427	CcSEcCtD
Loratadine—Hypertension—Prednisolone—psoriatic arthritis	0.000619	0.00419	CcSEcCtD
Loratadine—Arrhythmia—Betamethasone—psoriatic arthritis	0.000614	0.00416	CcSEcCtD
Loratadine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000614	0.00416	CcSEcCtD
Loratadine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000612	0.00414	CcSEcCtD
Loratadine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000611	0.00413	CcSEcCtD
Loratadine—Alopecia—Dexamethasone—psoriatic arthritis	0.000608	0.00411	CcSEcCtD
Loratadine—Alopecia—Betamethasone—psoriatic arthritis	0.000608	0.00411	CcSEcCtD
Loratadine—Discomfort—Prednisolone—psoriatic arthritis	0.000604	0.00408	CcSEcCtD
Loratadine—Angioedema—Triamcinolone—psoriatic arthritis	0.000603	0.00408	CcSEcCtD
Loratadine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000602	0.00407	CcSEcCtD
Loratadine—Malaise—Triamcinolone—psoriatic arthritis	0.000595	0.00403	CcSEcCtD
Loratadine—Malaise—Methylprednisolone—psoriatic arthritis	0.000594	0.00402	CcSEcCtD
Loratadine—Syncope—Triamcinolone—psoriatic arthritis	0.000592	0.004	CcSEcCtD
Loratadine—Syncope—Methylprednisolone—psoriatic arthritis	0.00059	0.004	CcSEcCtD
Loratadine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000586	0.00396	CcSEcCtD
Loratadine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00058	0.00392	CcSEcCtD
Loratadine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000579	0.00392	CcSEcCtD
Loratadine—Shock—Prednisolone—psoriatic arthritis	0.000576	0.0039	CcSEcCtD
Loratadine—Cough—Triamcinolone—psoriatic arthritis	0.000576	0.0039	CcSEcCtD
Loratadine—Tachycardia—Prednisolone—psoriatic arthritis	0.000572	0.00387	CcSEcCtD
Loratadine—Hypertension—Triamcinolone—psoriatic arthritis	0.00057	0.00386	CcSEcCtD
Loratadine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000568	0.00385	CcSEcCtD
Loratadine—Myalgia—Triamcinolone—psoriatic arthritis	0.000562	0.0038	CcSEcCtD
Loratadine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000561	0.00379	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—psoriatic arthritis	0.000558	0.00377	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000557	0.00377	CcSEcCtD
Loratadine—Depression—Methotrexate—psoriatic arthritis	0.000556	0.00376	CcSEcCtD
Loratadine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000556	0.00376	CcSEcCtD
Loratadine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000556	0.00376	CcSEcCtD
Loratadine—Discomfort—Triamcinolone—psoriatic arthritis	0.000555	0.00376	CcSEcCtD
Loratadine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000554	0.00375	CcSEcCtD
Loratadine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000549	0.00372	CcSEcCtD
Loratadine—Angioedema—Dexamethasone—psoriatic arthritis	0.000547	0.0037	CcSEcCtD
Loratadine—Angioedema—Betamethasone—psoriatic arthritis	0.000547	0.0037	CcSEcCtD
Loratadine—Immune system disorder—Prednisone—psoriatic arthritis	0.000541	0.00366	CcSEcCtD
Loratadine—Malaise—Dexamethasone—psoriatic arthritis	0.00054	0.00365	CcSEcCtD
Loratadine—Malaise—Betamethasone—psoriatic arthritis	0.00054	0.00365	CcSEcCtD
Loratadine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000539	0.00364	CcSEcCtD
Loratadine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000537	0.00364	CcSEcCtD
Loratadine—Syncope—Betamethasone—psoriatic arthritis	0.000537	0.00363	CcSEcCtD
Loratadine—Syncope—Dexamethasone—psoriatic arthritis	0.000537	0.00363	CcSEcCtD
Loratadine—Arrhythmia—Prednisone—psoriatic arthritis	0.000535	0.00362	CcSEcCtD
Loratadine—Shock—Triamcinolone—psoriatic arthritis	0.00053	0.00359	CcSEcCtD
Loratadine—Insomnia—Prednisolone—psoriatic arthritis	0.00053	0.00358	CcSEcCtD
Loratadine—Alopecia—Prednisone—psoriatic arthritis	0.000529	0.00358	CcSEcCtD
Loratadine—Shock—Methylprednisolone—psoriatic arthritis	0.000529	0.00358	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000527	0.00357	CcSEcCtD
Loratadine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000527	0.00357	CcSEcCtD
Loratadine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000526	0.00356	CcSEcCtD
Loratadine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000526	0.00356	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—psoriatic arthritis	0.000526	0.00356	CcSEcCtD
Loratadine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000526	0.00356	CcSEcCtD
Loratadine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000526	0.00356	CcSEcCtD
Loratadine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000524	0.00355	CcSEcCtD
Loratadine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000522	0.00353	CcSEcCtD
Loratadine—Hypertension—Dexamethasone—psoriatic arthritis	0.000517	0.0035	CcSEcCtD
Loratadine—Hypertension—Betamethasone—psoriatic arthritis	0.000517	0.0035	CcSEcCtD
Loratadine—Myalgia—Dexamethasone—psoriatic arthritis	0.00051	0.00345	CcSEcCtD
Loratadine—Myalgia—Betamethasone—psoriatic arthritis	0.00051	0.00345	CcSEcCtD
Loratadine—Discomfort—Dexamethasone—psoriatic arthritis	0.000504	0.00341	CcSEcCtD
Loratadine—Discomfort—Betamethasone—psoriatic arthritis	0.000504	0.00341	CcSEcCtD
Loratadine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000502	0.0034	CcSEcCtD
Loratadine—Pain—Prednisolone—psoriatic arthritis	0.000501	0.00339	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000497	0.00336	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000491	0.00332	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00049	0.00331	CcSEcCtD
Loratadine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000489	0.00331	CcSEcCtD
Loratadine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000489	0.00331	CcSEcCtD
Loratadine—Insomnia—Triamcinolone—psoriatic arthritis	0.000487	0.0033	CcSEcCtD
Loratadine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000486	0.00329	CcSEcCtD
Loratadine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000484	0.00327	CcSEcCtD
Loratadine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000484	0.00327	CcSEcCtD
Loratadine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000483	0.00327	CcSEcCtD
Loratadine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000482	0.00327	CcSEcCtD
Loratadine—Shock—Dexamethasone—psoriatic arthritis	0.000481	0.00325	CcSEcCtD
Loratadine—Shock—Betamethasone—psoriatic arthritis	0.000481	0.00325	CcSEcCtD
Loratadine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000479	0.00324	CcSEcCtD
Loratadine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000479	0.00324	CcSEcCtD
Loratadine—Agitation—Prednisone—psoriatic arthritis	0.000479	0.00324	CcSEcCtD
Loratadine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000477	0.00323	CcSEcCtD
Loratadine—Tachycardia—Betamethasone—psoriatic arthritis	0.000477	0.00323	CcSEcCtD
Loratadine—Angioedema—Prednisone—psoriatic arthritis	0.000476	0.00322	CcSEcCtD
Loratadine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000474	0.00321	CcSEcCtD
Loratadine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000473	0.0032	CcSEcCtD
Loratadine—Malaise—Prednisone—psoriatic arthritis	0.00047	0.00318	CcSEcCtD
Loratadine—Syncope—Prednisone—psoriatic arthritis	0.000468	0.00316	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—psoriatic arthritis	0.000467	0.00316	CcSEcCtD
Loratadine—Fatigue—Triamcinolone—psoriatic arthritis	0.000464	0.00314	CcSEcCtD
Loratadine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000463	0.00314	CcSEcCtD
Loratadine—Pain—Triamcinolone—psoriatic arthritis	0.000461	0.00312	CcSEcCtD
Loratadine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000458	0.0031	CcSEcCtD
Loratadine—Hypotension—Dexamethasone—psoriatic arthritis	0.000457	0.00309	CcSEcCtD
Loratadine—Hypotension—Betamethasone—psoriatic arthritis	0.000457	0.00309	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000452	0.00306	CcSEcCtD
Loratadine—Hypertension—Prednisone—psoriatic arthritis	0.00045	0.00305	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000445	0.00301	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000445	0.00301	CcSEcCtD
Loratadine—Myalgia—Prednisone—psoriatic arthritis	0.000444	0.003	CcSEcCtD
Loratadine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000444	0.003	CcSEcCtD
Loratadine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000443	0.003	CcSEcCtD
Loratadine—Alopecia—Methotrexate—psoriatic arthritis	0.000442	0.00299	CcSEcCtD
Loratadine—Insomnia—Betamethasone—psoriatic arthritis	0.000442	0.00299	CcSEcCtD
Loratadine—Insomnia—Dexamethasone—psoriatic arthritis	0.000442	0.00299	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000441	0.00298	CcSEcCtD
Loratadine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000439	0.00297	CcSEcCtD
Loratadine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000439	0.00297	CcSEcCtD
Loratadine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000439	0.00297	CcSEcCtD
Loratadine—Discomfort—Prednisone—psoriatic arthritis	0.000439	0.00297	CcSEcCtD
Loratadine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00043	0.00291	CcSEcCtD
Loratadine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00043	0.00291	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000427	0.00289	CcSEcCtD
Loratadine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000426	0.00288	CcSEcCtD
Loratadine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000426	0.00288	CcSEcCtD
Loratadine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000425	0.00287	CcSEcCtD
Loratadine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000422	0.00285	CcSEcCtD
Loratadine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000422	0.00285	CcSEcCtD
Loratadine—Fatigue—Dexamethasone—psoriatic arthritis	0.000421	0.00285	CcSEcCtD
Loratadine—Fatigue—Betamethasone—psoriatic arthritis	0.000421	0.00285	CcSEcCtD
Loratadine—Shock—Prednisone—psoriatic arthritis	0.000419	0.00283	CcSEcCtD
Loratadine—Pain—Dexamethasone—psoriatic arthritis	0.000418	0.00283	CcSEcCtD
Loratadine—Pain—Betamethasone—psoriatic arthritis	0.000418	0.00283	CcSEcCtD
Loratadine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000417	0.00282	CcSEcCtD
Loratadine—Tachycardia—Prednisone—psoriatic arthritis	0.000415	0.00281	CcSEcCtD
Loratadine—Skin disorder—Prednisone—psoriatic arthritis	0.000413	0.0028	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000404	0.00274	CcSEcCtD
Loratadine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000403	0.00273	CcSEcCtD
Loratadine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000403	0.00273	CcSEcCtD
Loratadine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0004	0.0027	CcSEcCtD
Loratadine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0004	0.0027	CcSEcCtD
Loratadine—Malaise—Methotrexate—psoriatic arthritis	0.000393	0.00266	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000388	0.00262	CcSEcCtD
Loratadine—Dizziness—Prednisolone—psoriatic arthritis	0.000387	0.00262	CcSEcCtD
Loratadine—Asthenia—Triamcinolone—psoriatic arthritis	0.000386	0.00261	CcSEcCtD
Loratadine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000386	0.00261	CcSEcCtD
Loratadine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000386	0.00261	CcSEcCtD
Loratadine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000386	0.00261	CcSEcCtD
Loratadine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000386	0.00261	CcSEcCtD
Loratadine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000386	0.00261	CcSEcCtD
Loratadine—Insomnia—Prednisone—psoriatic arthritis	0.000385	0.0026	CcSEcCtD
Loratadine—Paraesthesia—Prednisone—psoriatic arthritis	0.000382	0.00259	CcSEcCtD
Loratadine—Cough—Methotrexate—psoriatic arthritis	0.00038	0.00257	CcSEcCtD
Loratadine—Dyspepsia—Prednisone—psoriatic arthritis	0.000375	0.00254	CcSEcCtD
Loratadine—Chest pain—Methotrexate—psoriatic arthritis	0.000371	0.00251	CcSEcCtD
Loratadine—Myalgia—Methotrexate—psoriatic arthritis	0.000371	0.00251	CcSEcCtD
Loratadine—Rash—Prednisolone—psoriatic arthritis	0.000369	0.0025	CcSEcCtD
Loratadine—Dermatitis—Prednisolone—psoriatic arthritis	0.000369	0.0025	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000368	0.00249	CcSEcCtD
Loratadine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000368	0.00249	CcSEcCtD
Loratadine—Fatigue—Prednisone—psoriatic arthritis	0.000367	0.00248	CcSEcCtD
Loratadine—Headache—Prednisolone—psoriatic arthritis	0.000367	0.00248	CcSEcCtD
Loratadine—Discomfort—Methotrexate—psoriatic arthritis	0.000367	0.00248	CcSEcCtD
Loratadine—Constipation—Prednisone—psoriatic arthritis	0.000364	0.00246	CcSEcCtD
Loratadine—Dizziness—Triamcinolone—psoriatic arthritis	0.000356	0.00241	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000356	0.00241	CcSEcCtD
Loratadine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000355	0.0024	CcSEcCtD
Loratadine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000351	0.00237	CcSEcCtD
Loratadine—Asthenia—Betamethasone—psoriatic arthritis	0.000351	0.00237	CcSEcCtD
Loratadine—Asthenia—Dexamethasone—psoriatic arthritis	0.000351	0.00237	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000349	0.00236	CcSEcCtD
Loratadine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000348	0.00235	CcSEcCtD
Loratadine—Nausea—Prednisolone—psoriatic arthritis	0.000348	0.00235	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—psoriatic arthritis	0.000345	0.00234	CcSEcCtD
Loratadine—Vomiting—Triamcinolone—psoriatic arthritis	0.000342	0.00232	CcSEcCtD
Loratadine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000342	0.00231	CcSEcCtD
Loratadine—Rash—Triamcinolone—psoriatic arthritis	0.00034	0.0023	CcSEcCtD
Loratadine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000339	0.0023	CcSEcCtD
Loratadine—Rash—Methylprednisolone—psoriatic arthritis	0.000339	0.00229	CcSEcCtD
Loratadine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000338	0.00229	CcSEcCtD
Loratadine—Headache—Triamcinolone—psoriatic arthritis	0.000337	0.00228	CcSEcCtD
Loratadine—Headache—Methylprednisolone—psoriatic arthritis	0.000337	0.00228	CcSEcCtD
Loratadine—Abdominal pain—Prednisone—psoriatic arthritis	0.000336	0.00228	CcSEcCtD
Loratadine—Body temperature increased—Prednisone—psoriatic arthritis	0.000336	0.00228	CcSEcCtD
Loratadine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000334	0.00226	CcSEcCtD
Loratadine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000334	0.00226	CcSEcCtD
Loratadine—Hypotension—Methotrexate—psoriatic arthritis	0.000332	0.00225	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000324	0.00219	CcSEcCtD
Loratadine—Dizziness—Betamethasone—psoriatic arthritis	0.000323	0.00219	CcSEcCtD
Loratadine—Dizziness—Dexamethasone—psoriatic arthritis	0.000323	0.00219	CcSEcCtD
Loratadine—Insomnia—Methotrexate—psoriatic arthritis	0.000322	0.00218	CcSEcCtD
Loratadine—Nausea—Triamcinolone—psoriatic arthritis	0.00032	0.00216	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000319	0.00216	CcSEcCtD
Loratadine—Nausea—Methylprednisolone—psoriatic arthritis	0.000319	0.00216	CcSEcCtD
Loratadine—Somnolence—Methotrexate—psoriatic arthritis	0.000316	0.00214	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000313	0.00212	CcSEcCtD
Loratadine—Vomiting—Dexamethasone—psoriatic arthritis	0.000311	0.0021	CcSEcCtD
Loratadine—Vomiting—Betamethasone—psoriatic arthritis	0.000311	0.0021	CcSEcCtD
Loratadine—Rash—Betamethasone—psoriatic arthritis	0.000308	0.00209	CcSEcCtD
Loratadine—Rash—Dexamethasone—psoriatic arthritis	0.000308	0.00209	CcSEcCtD
Loratadine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000308	0.00208	CcSEcCtD
Loratadine—Dermatitis—Betamethasone—psoriatic arthritis	0.000308	0.00208	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000307	0.00208	CcSEcCtD
Loratadine—Fatigue—Methotrexate—psoriatic arthritis	0.000307	0.00208	CcSEcCtD
Loratadine—Headache—Dexamethasone—psoriatic arthritis	0.000306	0.00207	CcSEcCtD
Loratadine—Headache—Betamethasone—psoriatic arthritis	0.000306	0.00207	CcSEcCtD
Loratadine—Asthenia—Prednisone—psoriatic arthritis	0.000305	0.00207	CcSEcCtD
Loratadine—Pain—Methotrexate—psoriatic arthritis	0.000304	0.00206	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000293	0.00198	CcSEcCtD
Loratadine—Diarrhoea—Prednisone—psoriatic arthritis	0.000291	0.00197	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000291	0.00197	CcSEcCtD
Loratadine—Nausea—Dexamethasone—psoriatic arthritis	0.00029	0.00196	CcSEcCtD
Loratadine—Nausea—Betamethasone—psoriatic arthritis	0.00029	0.00196	CcSEcCtD
Loratadine—Dizziness—Prednisone—psoriatic arthritis	0.000281	0.0019	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000281	0.0019	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000281	0.0019	CcSEcCtD
Loratadine—Vomiting—Prednisone—psoriatic arthritis	0.000271	0.00183	CcSEcCtD
Loratadine—Rash—Prednisone—psoriatic arthritis	0.000268	0.00182	CcSEcCtD
Loratadine—Dermatitis—Prednisone—psoriatic arthritis	0.000268	0.00181	CcSEcCtD
Loratadine—Headache—Prednisone—psoriatic arthritis	0.000267	0.0018	CcSEcCtD
Loratadine—Asthenia—Methotrexate—psoriatic arthritis	0.000255	0.00173	CcSEcCtD
Loratadine—Nausea—Prednisone—psoriatic arthritis	0.000253	0.00171	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000243	0.00165	CcSEcCtD
Loratadine—Dizziness—Methotrexate—psoriatic arthritis	0.000235	0.00159	CcSEcCtD
Loratadine—Vomiting—Methotrexate—psoriatic arthritis	0.000226	0.00153	CcSEcCtD
Loratadine—Rash—Methotrexate—psoriatic arthritis	0.000224	0.00152	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—psoriatic arthritis	0.000224	0.00152	CcSEcCtD
Loratadine—Headache—Methotrexate—psoriatic arthritis	0.000223	0.00151	CcSEcCtD
Loratadine—Nausea—Methotrexate—psoriatic arthritis	0.000211	0.00143	CcSEcCtD
